Literature DB >> 15165113

Role of extracelluar regulated protein kinases in FTY720-induced apoptosis of leukemia cell lines HL-60 and U937.

Dengju Li1, Yaozhen Zhang, Xiangrong Hu, Wenjing Cao, Wei Huang.   

Abstract

The effects of a novel immunosuppressive agent FTY720 on proliferation inhibition and apoptosis of acute leukemia cell lines HL-60 and U937, and the role of extracelluar regulated protein kinase (ERK) in the course of proliferation inhibition and apoptosis induced by FTY720 were studied. The proliferation inhibition rate of HL-60 and U937 cells by various concentrations of FTY720 was detected by MTT assay. Cell apoptosis was detected by DNA fragment analysis and flow cytometry. The phosphorylated ERK1/2 protein expression was observed by Western blotting. The change of intracellular distribution of ERK1/2 protein was identified by SP immunohistochemical staining. The results showed that FTY720 could inhibit the growth of HL-60 and U937 cells effectively in a dose-dependent manner. After incubation with FTY720 for 24 h, apoptosis was observed in HL-60 and U937 cells. The intracellular expression of phosphorylated ERK1/2 protein was also down-regulated and the distribution of ERK1/2 protein in cell nuclear was reduced during FTY720-induced apoptosis. So, that FTY720 inhibited ERK1/2 phosphorylation might mediate the role of FTY720-induced apoptosis and proliferation inhibition of leukemia cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165113     DOI: 10.1007/bf02830703

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria.

Authors:  Y Nagahara; M Ikekita; T Shinomiya
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

2.  Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.

Authors:  X K Li; A Tamura; M Fujino; L Guo; T Kakefuda; N Funeshima; S Enosawa; M Amari; S Naoe; H Amemiya; S Suzuki
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway.

Authors:  S Matsuda; A Minowa; S Suzuki; S Koyasu
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

4.  An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis in HL-60.

Authors:  T Shinomiya; X K Li; H Amemiya; S Suzuki
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

5.  Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols.

Authors:  T Fujita; R Hirose; M Yoneta; S Sasaki; K Inoue; M Kiuchi; S Hirase; K Chiba; H Sakamoto; M Arita
Journal:  J Med Chem       Date:  1996-10-25       Impact factor: 7.446

6.  Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

Authors:  A Bonni; A Brunet; A E West; S R Datta; M A Takasu; M E Greenberg
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

7.  A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo.

Authors:  E Y Tsai; J V Falvo; A V Tsytsykova; A K Barczak; A M Reimold; L H Glimcher; M J Fenton; D C Gordon; I F Dunn; A E Goldfeld
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Identification of a functional Ca2+-sensing receptor in normal human gastric mucous epithelial cells.

Authors:  M J Rutten; K D Bacon; K L Marlink; M Stoney; C L Meichsner; F P Lee; S A Hobson; K D Rodland; B C Sheppard; D D Trunkey; K E Deveney; C W Deveney
Journal:  Am J Physiol       Date:  1999-09

9.  Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts.

Authors:  T Yamasaki; K Inoue; H Hayashi; Y Gu; H Setoyama; J Ida; W Cui; Y Kawakami; M Kogire; M Imamura
Journal:  Cell Transplant       Date:  1998 Jul-Aug       Impact factor: 4.139

  9 in total
  4 in total

Review 1.  Targeting sphingosine-1-phosphate in hematologic malignancies.

Authors:  Christina E Stevenson; Kazuaki Takabe; Masayuki Nagahashi; Sheldon Milstien; Sarah Spiegel
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

2.  FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells.

Authors:  Seon Min Woo; Bo Ram Seo; Kyoung-jin Min; Taeg Kyu Kwon
Journal:  Oncotarget       Date:  2015-05-10

Review 3.  Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies.

Authors:  Esther Melamed; Michael William Lee
Journal:  Front Immunol       Date:  2020-01-10       Impact factor: 7.561

Review 4.  The emerging role of FTY720 (Fingolimod) in cancer treatment.

Authors:  Christopher White; Heba Alshaker; Colin Cooper; Matthias Winkler; Dmitri Pchejetski
Journal:  Oncotarget       Date:  2016-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.